Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
CanadaIPO:
14 March 2012Website:
http://www.briacell.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 22:47:23 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is BriaCell Therapeutics?
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
What sector is BriaCell Therapeutics in?
BriaCell Therapeutics is in the Healthcare sector
What industry is BriaCell Therapeutics in?
BriaCell Therapeutics is in the Biotechnology industry
What country is BriaCell Therapeutics from?
BriaCell Therapeutics is headquartered in Canada
When did BriaCell Therapeutics go public?
BriaCell Therapeutics initial public offering (IPO) was on 14 March 2012
What is BriaCell Therapeutics website?
https://www.briacell.com
Is BriaCell Therapeutics in the S&P 500?
No, BriaCell Therapeutics is not included in the S&P 500 index
Is BriaCell Therapeutics in the NASDAQ 100?
No, BriaCell Therapeutics is not included in the NASDAQ 100 index
Is BriaCell Therapeutics in the Dow Jones?
No, BriaCell Therapeutics is not included in the Dow Jones index
When does BriaCell Therapeutics report earnings?
The next expected earnings date for BriaCell Therapeutics is 13 December 2024